Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy.

Rogers D, Nylander KD, Mi Z, Hu T, Schor NF.

Cancer Chemother Pharmacol. 2008 Sep;62(4):699-706. doi: 10.1007/s00280-008-0725-7. Epub 2008 Mar 13.

2.

Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2.

Mi Z, Hong B, Mirnics ZK, Tyurina YY, Kagan VE, Liang Y, Schor NF.

Cancer Chemother Pharmacol. 2006 Feb;57(3):357-67. Epub 2005 Jul 5.

PMID:
16001169
3.
4.

UCN-01 alters phosphorylation of Akt and GSK3beta and induces apoptosis in six independent human neuroblastoma cell lines.

Shankar SL, Krupski M, Parashar B, Okwuaka C, O'Guin K, Mani S, Shafit-Zagardo B.

J Neurochem. 2004 Aug;90(3):702-11.

5.

Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin.

Hartsell TL, Yalowich JC, Ritke MK, Martinez AJ, Schor NF.

J Pharmacol Exp Ther. 1995 Oct;275(1):479-85.

PMID:
7562588
6.

Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2.

Cortazzo M, Schor NF.

Cancer Res. 1996 Mar 15;56(6):1199-203.

7.

Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.

Carlsson E, Krohn K, Ovaska K, Lindberg P, Häyry V, Maliniemi P, Lintulahti A, Korja M, Kivisaari R, Hussein S, Sarna S, Niiranen K, Hautaniemi S, Haapasalo H, Ranki A.

Genes Chromosomes Cancer. 2013 Feb;52(2):191-201. doi: 10.1002/gcc.22019. Epub 2012 Oct 25.

PMID:
23097141
8.

Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2.

Liang Y, Nylander KD, Yan C, Schor NF.

Mol Pharmacol. 2002 Jan;61(1):142-9.

9.

Apoptosis in the absence of caspase 3.

Liang Y, Yan C, Schor NF.

Oncogene. 2001 Oct 4;20(45):6570-8.

10.

Neocarzinostatin induces neuronal morphology of mouse neuroblastoma in culture.

Schor NF.

J Pharmacol Exp Ther. 1989 Jun;249(3):906-10.

PMID:
2525186
11.

ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα.

Sinha S, Ghildiyal R, Mehta VS, Sen E.

Cell Death Dis. 2013 May 2;4:e615. doi: 10.1038/cddis.2013.128.

12.

Elevated expression of Dickkopf-1 increases the sensitivity of human glioma cell line SHG44 to BCNU.

Zhou Y, Li W, Xu Q, Huang Y.

J Exp Clin Cancer Res. 2010 Oct 4;29:131. doi: 10.1186/1756-9966-29-131.

13.

Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells.

Fang J, Gu L, Zhu N, Tang H, Alvarado CS, Zhou M.

BMC Cancer. 2008 Mar 6;8:69. doi: 10.1186/1471-2407-8-69.

14.

Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.

Dole MG, Jasty R, Cooper MJ, Thompson CB, Nuñez G, Castle VP.

Cancer Res. 1995 Jun 15;55(12):2576-82.

16.

Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.

Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, Reed JC.

Am J Pathol. 1997 Mar;150(3):805-14.

17.

siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.

Lei XY, Zhong M, Feng LF, Zhu BY, Tang SS, Liao DF.

Clin Exp Pharmacol Physiol. 2007 May-Jun;34(5-6):450-6.

PMID:
17439414
18.

Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophore.

Urbaniak MD, Frost LM, Bingham JP, Kelland LR, Hartley JA, Woolfson DN, Caddick S.

Bioorg Med Chem Lett. 2003 Jun 16;13(12):2025-7.

PMID:
12781188
19.

Early events in Bcl-2-enhanced apoptosis.

Liang Y, Yan C, Nylander KD, Schor NF.

Apoptosis. 2003 Dec;8(6):609-16.

PMID:
14739606
20.

Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo.

Song J, Hou L, Ju C, Zhang J, Ge Y, Yue W.

Eur J Pharmacol. 2013 Feb 28;702(1-3):235-41. doi: 10.1016/j.ejphar.2013.01.017. Epub 2013 Jan 29.

PMID:
23376416

Supplemental Content

Support Center